Optical imaging of cancer-related proteases using near-infrared fluores-cence matrix metalloproteinase-sensitive and cathepsin B-sensitive probes

Theranostics

Volumn 2, Issue 2, 2012, Pages 179-189

  Yhee, Ji Young ^a   Kim, Sun Ah ^a   Koo, Heebeom ^a   Son, Sohee ^a   Ryu, Ju Hee ^a   Youn, In Chan ^a   Choi, Kuiwon ^a   Kwon, Ick Chan ^a   Kim, Kwangmeyung ^a  

^a Korea Institute of Science and Technology   (South Korea)

Author keywords

Cathepsin B; Matrix metalloproteinase; Polymer nanoparticle

Indexed keywords

CATHEPSIN B; FLUORESCENT DYE; MATRIX METALLOPROTEINASE; PROTEINASE; TUMOR PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CONJUGATION; CONTROLLED STUDY; CYTOPLASM; ENZYME SPECIFICITY; EXTRACELLULAR MATRIX; FLUORESCENCE; IN VIVO STUDY; MOLECULAR IMAGING; MOUSE; NANOPROBE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; OPTICS; SENSITIVITY ANALYSIS; TUMOR GROWTH;

EID: 84864538137     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.3716     Document Type: Article

References (38)

1. Levi J, Kothapalli SR, Ma TJ, Hartman K, Khuri-Yakub BT, Gambhir SS. Design, synthesis, and imaging of an activatable photoacoustic probe. J Am Chem Soc. 2010; 132: 11264-9.
2. Weissleder R. Molecular imaging in cancer. Science. 2006; 312: 1168-71.
3. Kim GB, Kim Y. Analysis of protease activity using Quantum dots and resonance energy transfer. Theranostics. 2012; 2: e0004.
4. Blum G, von Degenfeld G, Merchant MJ, Blau HM, Bogyo M. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. Nat Chem Biol. 2007; 3: 668-77.
5. Zheng G, Chen J, Stefflova K, Jarvi M, Li H, Wilson BC. Pho-todynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and ac-tivation. Proc Natl Acad Sci U S A. 2007; 104: 8989-94.
6. Lee S, Ryu JH, Park K, Lee A, Lee SY, Youn IC, et al. Polymeric nanoparticle-based activatable near-infrared nanosensor for protease determination in vivo. Nano Lett. 2009; 9: 4412-6.
7. Ryu JH, Kim SA, Koo H, Yhee JY, Lee A, Na JH, et al. Cathepsin B-sensitive nanoprobe for in vivo tumor diagnosis. J Mater Chem. 2011; DOI: 10.1039/C1JM13064A
8. Law B, Curino A, Bugge TH, Weissleder R, Tung CH. Design, synthesis, and characterization of urokinase plasmino-gen-activator-sensitive near-infrared reporter. Chem Biol. 2004; 11: 99-106.
9. Zhu L, Xie J, Swierczewska M, Zhang F, Quan Q, Ma Y, et al. Real-time video imaging of protease expression in vivo. Theranostics. 2011; 1: 18-27.
10. Lu J, Zhang Z, Yang J, Chu J, Li P, Zeng S, et al. Visualization of beta-secretase cleavage in living cells using a genetically en-coded surface-displayed FRET probe. Biochem Biophys Res Commun. 2007; 362: 25-30.
11. Lin J, Zhang Z, Yang J, Zeng S, Liu BF, Luo Q. Real-time detection of caspase-2 activation in a single living HeLa cell during cisplatin-induced apoptosis. J Biomed Opt. 2006; 11: 024011.
12. Chen Y, Liang G. Video imaging of protease expression in vivo. Theranostics. 2012; 2: e0012.
13. Jang B, Choi Y. Photosensitizer-conjugated Gold Nanorods for Enzyme-Activatable Fluorescence Imaging and Photodynamic Therapy. Theranostics. 2012; 2: e0005.
14. Zucker S. A critical appraisal of the role of proteolytic enzymes in cancer invasion: emphasis on tumor surface proteinases. Cancer Invest. 1988; 6: 219-31.
15. Koblinski JE, Ahram M, Sloane BF. Unraveling the role of proteases in cancer. Clin Chim Acta. 2000; 291: 113-35.
16. Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell. 1996; 85: 683-93.
17. Ala-aho R, Kahari VM. Collagenases in cancer. Biochimie. 2005; 87: 273-86.
18. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002; 2: 161-74.
19. Yamada T, Oshima T, Yoshihara K, Tamura S, Kanazawa A, Inagaki D, et al. Overexpression of MMP-13 gene in colorectal cancer with liver metastasis. Anticancer Res. 2010; 30: 2693-9.
20. Crawford HC, Scoggins CR, Washington MK, Matrisian LM, Leach SD. Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas. J Clin Invest. 2002; 109: 1437-44.
21. Scorilas A, Karameris A, Arnogiannaki N, Ardavanis A, Bassilopoulos P, Trangas T, et al. Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients. Br J Cancer. 2001; 84: 1488-96.
22. Hulkower KI, Butler CC, Linebaugh BE, Klaus JL, Keppler D, Giranda VL, et al. Fluorescent microplate assay for cancer cell-associated cathepsin B. Eur J Biochem. 2000; 267: 4165-70.
23. Lopez-Otin C, Matrisian LM. Emerging roles of proteases in tumour suppression. Nat Rev Cancer. 2007; 7: 800-8.
24. Ebert MP, Kruger S, Fogeron ML, Lamer S, Chen J, Pross M, et al. Overexpression of cathepsin B in gastric cancer identified by proteome analysis. Proteomics. 2005; 5: 1693-704.
25. Kruszewski WJ, Rzepko R, Wojtacki J, Skokowski J, Kopacz A, Jaskiewicz K, et al. Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma. Neoplasma. 2004; 51: 38-43.
26. Kawada A, Hara K, Kominami E, Kobayashi T, Hiruma M, Ishibashi A. Cathepsin B and D expression in squamous cell carcinoma. Br J Dermatol. 1996; 135: 905-10.
27. Lorenzo K, Ton P, Clark JL, Coulibaly S, Mach L. Invasive properties of murine squamous carcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6-phosphate/insulin-like growth factor II receptor. Cancer Res. 2000; 60: 4070-6.
28. Pham W, Choi Y, Weissleder R, Tung CH. Developing a peptide-based near-infrared molecular probe for protease sensing. Bioconjug Chem. 2004; 15: 1403-7.
29. van Duijnhoven SM, Robillard MS, Nicolay K, Grull H. Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation. J Nucl Med. 2011; 52: 279-86.
30. Ryu JH, Lee A, Huh MS, Chu J, Kim K, Kim BS, Choi K, Kwon IC, Park JW, Youn I. Measurement of MMP activity in synovial fluid in cases of osteoarthritis and acute inflammatory conditions of the knee joints using a fluorogenic peptide probe-immobilized diagnostic kit. Theranostics. 2012; 2: e0008.
31. Koo H, Lee H, Lee S, Min KH, Kim MS, Lee DS, et al. In vivo tumor diagnosis and photodynamic therapy via tumoral pH-responsive polymeric micelles. Chem Commun (Camb). 2010; 46: 5668-70.
32. Koo H, Huh M.S., Ryu J.H., Lee D.-E, Sun I.-C, Choi K., Kim K., Kwon I.C. Nanoprobes for biomedical imaging in living sys-tems. Nano Today. 2011; 6: 201-20.
33. Roebuck MM, Helliwell TR, Chaudhry IH, Kalogrianitis S, Carter S, Kemp GJ, et al. Matrix metalloproteinase expression is related to angiogenesis and histologic grade in spindle cell soft tissue neoplasms of the extremities. Am J Clin Pathol. 2005; 123: 405-14.
34. Sun IC, Eun DK, Koo H, Ko CY, Kim HS, Yi DK, et al. Tumor-targeting gold particles for dual computed tomography/optical cancer imaging. Angew Chem Int Ed Engl. 2011; 50: 9348-51.
35. Emmert-Buck MR, Roth MJ, Zhuang Z, Campo E, Rozhin J, Sloane BF, et al. Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol. 1994; 145: 1285-90.
36. Liotta LA, Stetler-Stevenson WG. Metalloproteinases and cancer invasion. Semin Cancer Biol. 1990; 1: 99-106.
37. Zhang B, Cao X, Liu Y, Cao W, Zhang F, Zhang S, et al. Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer. BMC Cancer. 2008; 8: 83.
38. Holtkamp N, Atallah I, Okuducu AF, Mucha J, Hartmann C, Mautner VF, et al. MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumors. Neoplasia. 2007; 9: 671-7.